1.Ma J, Xu X, Fu C, Xia P, Tian M, Zheng L, Chen K, Liu X, Li Y, Yu L, Zhu Q,
Yu Y, Fan R, Jiang H, Li Z, Yang C, Xu C, Long Y, Wang J, Li Z. CDH17 nanobodies
facilitate rapid imaging of gastric cancer and efficient delivery of
immunotoxin. Biomater Res. 2022 Nov 26;26(1):64. doi:
10.1186/s40824-022-00312-3. PMID: 36435809; PMCID: PMC9701387.
2. Jacobsen F, Pushpadevan R, Viehweger F, Freytag M, Schlichter R, Gorbokon N,
Büscheck F, Luebke AM, Putri D, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D,
Fraune C, Bernreuther C, Lebok P, Sauter G, Minner S, Steurer S, Simon R,
Burandt E, Dum D, Lutz F, Marx AH, Krech T, Clauditz TS. Cadherin-17 (CDH17)
expression in human cancer: A tissue microarray study on 18,131 tumors. Pathol
Res Pract. 2024 Apr;256:155175. doi: 10.1016/j.prp.2024.155175. Epub 2024 Jan
28. PMID: 38452580.
3. Feng Z, He X, Zhang X, Wu Y, Xing B, Knowles A, Shan Q, Miller S, Hojnacki T,
Ma J, Katona BW, Gade TPF, Siegel DL, Schrader J, Metz DC, June CH, Hua X.
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by
CDH17CAR T cells without toxicity to normal tissues. Nat Cancer. 2022
May;3(5):581-594. doi: 10.1038/s43018-022-00344-7. Epub 2022 Mar 21. Erratum in:
Nat Cancer. 2024 Apr;5(4):691. doi: 10.1038/s43018-024-00766-5. PMID: 35314826.